Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyperparathyroidism, Secondary”

265 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 265 results

Not applicableStudy completedNCT04637360
What this trial is testing

Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment

Who this might be right for
Hyperparathyroidism; Secondary, Renal
Min-Sheng General Hospital 40
Post-approval studies (Phase 4)Study completedNCT00110890
What this trial is testing

A Research Study for Patients With End-Stage Renal Disease (ESRD)

Who this might be right for
End Stage Renal Disease
Amgen 552
Not applicableEnded earlyNCT01134315
What this trial is testing

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Who this might be right for
Secondary HyperparathyroidismEnd-Stage Renal Disease
AbbVie (prior sponsor, Abbott) 61
Not applicableStudy completedNCT00999037
What this trial is testing

FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease

Who this might be right for
Secondary Hyperparathyroidism
University of California, Los Angeles 18
Not applicableStudy completedNCT00037193
What this trial is testing

Acute Regulation of Parathyroid Hormone by Dietary Phosphate

Who this might be right for
Secondary Hyperparathyroidism
National Center for Research Resources (NCRR)
Post-approval studies (Phase 4)Study completedNCT00454350
What this trial is testing

Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis

Who this might be right for
Secondary Hyperparathyroidism
Genzyme, a Sanofi Company 12
Not applicableUnknownNCT02332135
What this trial is testing

The Efficacy and Safety of Microwave Ablation for Mild-to-moderate Secondary Hyperparathyroidism Patients Undergoing Hemodialysis

Who this might be right for
Secondary HyperparathyroidismMaintenance Hemodialysis
Wenhu Liu 30
Post-approval studies (Phase 4)Ended earlyNCT00646282
What this trial is testing

Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney Transplant Patients

Who this might be right for
Hyperparathyroidism, Secondary
Emory University 12
Testing effectiveness (Phase 2)Looking for participantsNCT06906874
What this trial is testing

Activated Charcoal Use in Chronic Kidney Disease Patients

Who this might be right for
End Stage Renal Disease (ESRD)CKD 5D, HemodialysisCKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder
Mansoura University 40
Testing effectiveness (Phase 2)Study completedNCT00742716
What this trial is testing

Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal Insufficiency+1 more
OPKO IP Holdings II, Inc. 41
Early research (Phase 1)Study completedNCT01167309
What this trial is testing

LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients

Who this might be right for
Secondary Hyperparathyroidism
LEO Pharma 72
Not applicableStudy completedNCT01265992
What this trial is testing

Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
AbbVie (prior sponsor, Abbott) 50
Post-approval studies (Phase 4)Study completedNCT01181531
What this trial is testing

Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 312
Large-scale testing (Phase 3)Study completedNCT04750460
What this trial is testing

Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease-Mineral and Bone DisorderDialysis+2 more
Saint Petersburg State University, Russia 20
Post-approval studies (Phase 4)Study completedNCT01100723
What this trial is testing

Trial to Optimize Mineral Outcomes in Dialysis Patients

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
University of Colorado, Denver 92
Testing effectiveness (Phase 2)Study completedNCT06690242
What this trial is testing

MT1013 Injection for the Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 115
Not applicableStudy completedNCT01081665
What this trial is testing

Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent and Treat Secondary Hyperparathyroidism

Who this might be right for
Chronic Kidney FailureSecondary Hyperparathyroidism
Abbott 237
Large-scale testing (Phase 3)Study completedNCT01578200
What this trial is testing

Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study

Who this might be right for
HemodialysisHyperphosphatemia
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 2,309
Not applicableStudy completedNCT05460234
What this trial is testing

RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients

Who this might be right for
Chronic Kidney Disease
Vifor (International) Inc. 110
Large-scale testing (Phase 3)Study completedNCT01191762
What this trial is testing

Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease

Who this might be right for
HyperparathyroidismChronic Kidney Disease
Kenneth R. Phelps, M.D. 30
Load More Results